Current pharmacotherapy options for cancer anorexia and cachexia. - Wikidata - awgldk - TriplyDB

Current pharmacotherapy options for cancer anorexia and cachexia.

Current pharmacotherapy options for cancer anorexia and cachexia.

http://www.wikidata.org/entity/Q38052613

about

Cachexia and pancreatic cancer: are there treatment options?Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Two ghrelin receptor agonists for adults with malnutrition: a systematic review and meta-analysis Effect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapy An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin.Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders The effectiveness of nutritional interventions in malnutrition and cachexia.Advances in pharmacologic strategies for cancer cachexia.The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.Novel therapeutic options for cachexia and sarcopenia.Update on Management of Cancer-Related Cachexia.Cancer, cachexia, prostanoids, and NSAIDs.

P2860

Q27026558-01F3B73B-C306-418A-A115-968C04D393B6 Q28068034-FEE23792-64C0-4F87-B1F5-3E94EC15F26F Q28079897-E24301C8-0D6B-4AFB-9D26-AF1EC80CA585 Q33831232-DEF078D2-9B7A-4BD3-94F2-A043EA3D4A12 Q34672667-759021FE-B88F-4359-8F1C-B43334CCFF4C Q36311252-6D3854A2-9D87-4E26-9DAA-CDF07A8C3704 Q36673441-DB1992A3-A333-4C82-93F5-C10F5D8519A0 Q38155361-D8D2068B-B4FF-48FC-BF69-849093B6BC61 Q38531286-7ED81FD9-4161-48F1-8665-A51F069CB04A Q38578582-8D879F9C-E9DB-4AB1-9C76-FA033AAA903D Q38670238-E0824555-31A4-4830-9DB3-D1E32013C2FE Q38887581-095DAB97-07E2-4557-91F7-B0DC696BF7C7 Q38990581-6EAB7C2C-1FD7-46E1-95D4-A0C915E5D542 Q46170824-9E0640E2-0639-48B1-8099-3D21849834A1

P2860

Current pharmacotherapy options for cancer anorexia and cachexia.

http://www.wikidata.org/entity/Q38052613

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current pharmacotherapy options for cancer anorexia and cachexia.

@en

type

label

Current pharmacotherapy options for cancer anorexia and cachexia.

@en

prefLabel

Current pharmacotherapy options for cancer anorexia and cachexia.

@en

P1433

Q38052613-EB353880-D13B-4C61-9F94-FDBDDD8CD265

P1476

Q38052613-1337A953-0679-4AD2-91C3-D5B71FFB1989

P2093

Q38052613-6913310E-BC6A-4480-8639-DE88E3A86857

Q38052613-69664680-1414-4036-BE56-910A94FA7D61

Q38052613-6D8D3281-F6DE-4C29-8095-7FAD10F4FE8C

P2860

Q38052613-0E1B080E-4624-43D3-8AED-E736D1D77B72

Q38052613-0E2891AE-6709-4143-AE9D-B6A5EFF367AB

Q38052613-1133F969-0C39-495A-8548-D1AC517EF67F

Q38052613-1210E34B-D9C1-4DC9-B8F9-377B04F7214E

Q38052613-15A28B5E-5491-450C-A272-D21A36E2F194

Q38052613-15BC53F5-6FB3-4A3E-A925-E828ACE1F19C

Q38052613-19F0D775-9C51-4CED-828E-13EA2D917020

Q38052613-1C7A5935-0B76-4759-9752-1CE4E254BD35

Q38052613-1F5C80E4-2BCF-4551-AE6C-2019B4D2E2FC

Q38052613-222492B0-E4AE-49B1-A0CC-20414793D6F2

P304

Q38052613-E457F4C4-ABD5-4F9B-ADD2-CB76CC2941DE

P31

Q38052613-563A7DAA-2537-43DE-BD16-86233F3FDD0F

P356

Q38052613-44F7E606-C276-494F-8A59-DB5599D77CBD

P407

Q38052613-AA8AA109-4558-4F33-BF7C-726CAB185346

P433

Q38052613-360690FF-0814-46E8-9929-B3418C22C780

P478

Q38052613-C89FA473-3E92-46AD-B1FB-DB2881E16FB6

P577

Q38052613-EBC1BDF5-9D9F-4C11-BEE5-3D02312BD874

P5875

Q38052613-DF43A6E7-D7B1-4E72-981F-9D74A565380E

P698

Q38052613-B404297D-0A82-4DE4-A10C-C0ED8C0342CF

P921

Q38052613-93D28916-FF1A-4F90-B168-F0E7A455D36F

P356

14656566.2012.734297

P1433

Expert Opinion on Pharmacotherapy

P1476

Current pharmacotherapy options for cancer anorexia and cachexia.

@en

P2093

Antonio Macciò

http://www.w3.org/2001/XMLSchema#string

Clelia Madeddu

http://www.w3.org/2001/XMLSchema#string

Giovanni Mantovani

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia

Nutritional support in multimodal therapy for cancer cachexia

A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)

Turning toward dissonance: lessons from art, music, and literature.

Emergence of ghrelin as a treatment for cachexia syndromes.

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting

Nutritional support of the cancer patient: issues and dilemmas.

Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.

P304

2453-2472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.734297

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232276893

http://www.w3.org/2001/XMLSchema#string

P698

23072481

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy